Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in the Philippines, 2012-2018
- PMID: 35251742
- PMCID: PMC8873914
- DOI: 10.5365/wpsar-2021.12.4.834
Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in the Philippines, 2012-2018
Abstract
Objective: Data are scarce on the prevailing Streptococcus pneumoniae serotypes in the Philippines, including the relative antimicrobial resistance (AMR) of these bacteria. This study is designed to fill that gap by describing the serotype distribution and AMR of S. pneumoniae in the Philippines from 2012 to 2018.
Methods: S. pneumoniae isolates from clinical specimens were collected through the Philippine Department of Health Antimicrobial Resistance Surveillance Program from 1 January 2012 to 31 December 2018. Identification and antimicrobial susceptibility testing (AST) were performed using conventional and automated methods (Vitek2 Compact Automated Machine). AST for penicillin, erythromycin, co-trimoxazole, ceftriaxone and levofloxacin was done following the Clinical and Laboratory Standard Institute recommendations. Serotyping was done through slide agglutination following the Denka Seiken slide agglutination method.
Results: From a total of 307 isolates of S. pneumoniae, 32 serotypes were identified; the most frequently occurring were serotypes 1, 3, 5, 4, 18, 19A, 6B, 15 and 14. Many (n = 113, 36.53%) of the isolates were from those aged £5 years. Pneumococcal conjugate vaccine (PCV) coverage was as follows: PCV7 (32.69%), PCV10 (54.16%) and PCV13 (69.23%). The overall AMR of invasive S. pneumoniae isolates was low. Penicillin-resistant serotypes were 14, 19, 24, 4, 5, 1, 15, 6 and 32.
Discussion: With the inclusion of PCV13 in the National Immunization Program, continued monitoring of the prevailing serotypes of S. pneumoniae isolates in the Philippines is needed to guide disease and AMR control measures.
(c) 2021 The authors; licensee World Health Organization.
Figures
References
-
- Pneumonia. Geneva: World Health Organization; 2019. Available from: https://www.who.int/en/news-room/fact-sheets/detail/pneumonia, accessed 30 August 2021.
-
- GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study. Lancet Infect Dis. 2018. Nov;18(11):1191–210. 10.1016/S1473-3099(18)30310-4 - DOI - PMC - PubMed
-
- Invasive pneumococcal disease – annual epidemiological report for 2016. Stockholm: European Centre for Disease Prevention and Control; 2016. Available from: https://www.ecdc.europa.eu/en/publications-data/invasive-pneumococcal-di..., accessed 30 August 2021.
-
- Wardlaw TM, Johansson EW, Hodge M. World Health Organization & United Nations Children’s Fund (UNICEF). Pneumonia: the forgotten killer of children. Geneva: World Health Organization; 2014. [cited 2021 August 30]. Available from: Available from https://apps.who.int/iris/handle/10665/43640
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous